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Abstract
Purpose Flaxseed can be effective at lowering and stabilising blood glucose responses. The aim of this study was to deter-
mine whether flaxseed could lower blood glucose response more effectively when consumed as a single portion of 30 g, or 
a split portion consumed three times per day (10 g flaxseed per portion).
Methods The study was a randomised, repeated measures, cross-over design. Fifteen healthy participants consumed either 
(1) three flaxseed muffins containing a total of 30 g of flaxseed once in the morning, (2) three flaxseed muffins consumed at 
three different timepoints across the day (10 g flaxseed per muffin) or (3) three control muffins consumed at three different 
timepoints across the day (0 g flaxseed). The 24-h blood glucose response was measured using a continuous glucose monitor.
Results The results of this study demonstrated that flaxseed muffins given three times a day were effective at lowering and 
maintaining blood glucose levels over 24 h, compared to the control muffins and that both flaxseed treatments resulting in a 
lower blood glucose iAUC during the night.
Conclusion The results of this study indicated that adding flaxseed to a daily diet produced a lower glucose profile over 24 h 
in a free-living context compared to the control muffins.
Keywords Flaxseed · Linseed · Blood glucose · Continuous glucose monitor · Blood glucose incremental area under the 
curve (iAUC) · 24 blood glucose profile
Introduction
There is a considerable body of evidence indicating that 
the consumption of low glycemic index (GI) foods reduces 
blood glucose fluctuations, and benefits the management and 
prevention of diabetes and prediabetes [1–3]. Low GI foods 
help to stabilise blood responses at a normal level for longer 
period of time [4] minimising potentially large fluctuations in 
blood glucose levels [2, 5]. Epidemiological evidence suggests 
that postprandial blood glucose levels are more strongly related 
to cardiovascular events than fasting blood glucose in individu-
als with diabetes [6, 7]. Current eating patterns can mean that 
a high proportion of the day is spent in the postprandial state, 
which produces the highest plasma glucose levels [8].
Foods which contain a high amount of fibre gener-
ally have a lower postprandial blood glucose and insulin 
response, a lower GI, and are more effective at preventing 
type two diabetes in healthy individuals [1]. Flaxseed is con-
sidered to be one of the key plant sources of dietary fibre, 
as it contains both soluble and insoluble fibre with a ratio of 
soluble to insoluble varying between 20:80 and 40:60. The 
soluble fibre in flaxseed is mucilage gum and insoluble fibre 
is cellulose, hemicellulose and lignin [9, 10].
Previous studies have demonstrated that flaxseed can 
be effective at lowering and stabilising the blood glucose 
response in healthy, pre-diabetic and diabetic individuals 
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[11–15]. The question remains as to whether flaxseed is 
more effective at maintaining blood glucose at the normal 
level over 24 h when the portion is given once or spread out 
throughout the day. The majority of studies on flaxseed and 
glycaemic response gathered the data in a laboratory setting 
the morning after an overnight fast, which does not represent 
the physiological responses across a full day.
Continuous glucose monitoring systems (CGMS) provide 
a method of evaluating subcutaneous interstitial fluid glu-
cose over a number of days, by applying an electrochemical 
detector under free-living conditions [16]. CGMS evalu-
ates interstitial glucose concentrations every 5 min and are 
minimally invasive, which gives an opportunity to evaluate 
the direction, magnitude, duration, frequency and causes of 
fluctuations in blood glucose levels [16, 17]. It can give a 
detailed view of the blood glucose profile, which can poten-
tially show when and to what extent, an intervention affects 
the glycaemic response, while allowing the participants to 
continue their daily lives and activities uninterrupted [5, 18].
Currently, to best of our knowledge, no study has inves-
tigated the effect of splitting a portion of flaxseed on blood 
glucose control, or whether the flaxseed is more effective 
administered in a single or split portion. In the current study, 
the flaxseed portion was split over the three meals, which 
may cause a lower blood glucose post each of the three 
meals. The aim of this study, therefore, was to determine 
the most effective timing of flaxseed consumption to lower 
blood glucose response in healthy participants. This study 
used a single and a split portion regimen and investigated the 
blood glucose response over a 24-h period using a CGMS 
to determine whether flaxseed was more effective when 
consumed as a single portion of 30 g or as a split portion 
consumed three times per day (10 g flaxseed per portion).
Materials and methods
Participants
Healthy male and female adults aged between 18–60 years 
were recruited into this study at Oxford Brookes Univer-
sity through advertisements containing the researcher con-
tact details between March 2017 and November 2017. The 
inclusion criteria were; aged 18–65 years; Body mass index 
(BMI) ≤ 30 kg/m2; fasting blood glucose < 6.1 mmol/l; not-
pregnant or lactating; no known diabetes or impaired glu-
cose tolerance; no medical condition(s) or medication(s) 
known to affect glucose regulation or appetite and/or which 
influence digestion and absorption of nutrients; no major 
medical or surgical event requiring hospitalisation within 
the preceding three months; and no food allergy or intol-
erance to any of the study foods. Ethical approval for the 
study has been obtained from the University Research Ethics 
Committee at Oxford Brookes University (UREC Registra-
tion No: 161046).
Study design
The study was a randomised, cross-over repeated measures 
design. Participants undertook seven visits in total, the first 
was the screening visit, three initial sessions for sensor inser-
tion and three follow-up sessions for sensor removal.
Consent and screening
During the screening visit, participants were asked to sign a 
consent form and to complete a health questionnaire, which 
included questions regarding to food allergies/intolerances, 
metabolic diseases, smoking habits, physical activity, 
medical conditions and medication. After completing the 
questionnaire, the following anthropometric measurements 
were taken: height using a free-standing stadiometer (SECA, 
Germany), body weight, body fat percent and fat-free mass 
using the Tanita body composition analyser (BC-418, Tanita 
UK Ltd, Middlesex, UK). Height was recorded to the nearest 
0.1 cm and body weight was recorded to the nearest 0.1 kg. 
If the participants were eligible after taking the anthropo-
metric measurements and did not have any of the exclusion 
criteria, then a fasting (overnight for 12 h) blood glucose 
measurement was taken from a finger-prick blood sample to 
determine the baseline data for glucose and if the participant 
was eligible to participate in the study.
Test days
At the initial sessions the CGMS sensor was inserted under 
the skin in the abdominal region between 15.00–17.00 h the 
day before the test day. Participants collected food for the 
test day, as well as prepared food for an evening meal the day 
before the test day. This ensured all participants began the 
test day following a similar meal. There was no need to fast 
for the sensor insertion session and there were no restrictions 
on the types of clothes that could be worn.
Participants were required to remain at the Oxford 
Brookes Centre for Nutrition and Health for 1 h to allow 
the sensor to initialise after trained personnel inserted the 
sensor. The participants were required to take four capillary 
finger-prick blood glucose readings using a single use lanc-
ing system (Unistik 3, Owen Munford, Woodstock, UK). 
The readings needed to be taken one and 2 h after the inser-
tion of the sensor, before dinner and before bedtime. The 
purpose of the capillary finger-pricks was to calibrate the 
CGMS sensor.
All participants were provided with a finger-prick blood 
glucose monitoring device (ACCU-CHEK® Performa 
Nano, Roche Diabetes Care Limited, Burgess Hill UK). 
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Participants were provided with written instructions on using 
the device and performing a capillary finger-prick; all par-
ticipants were also trained to carry on taking blood glucose 
readings by themselves while the sensor was inserted, par-
ticipants were required to avoid alcohol and restrict intense 
physical activity (e.g., long periods at the gym, running, 
aerobics). Dinner on pre-test day needed to be consumed 
between 18.00 and 20.00 h.
On the test day which came the day after sensor inser-
tion, the participants were required to take four capillary 
finger-pricks to measure blood glucose readings following 
the same procedure as the day prior the test day (before each 
main meal and before bedtime). Participants were aware of 
how to follow the correct procedures to dispose of the waste 
safely and they were provided with a clinical waste bin to 
dispose of all the items after use.
The participants were instructed about when to take their 
meals on the test day; breakfast between 7.00 and 9.00 h, the 
first snack between 10.00 and 11.00 h, lunch between 12.00 
and 14.00 h, the second snack between 16.00 and 17.00 h 
and dinner between 18.00 and 20.00 h. They were told not 
to consume any food or drink which was not provided, apart 
from water and hot drinks such as tea, coffee or herbal tea. 
They were asked to record all drinks consumed.
On the three test days: participants randomly consumed 
either control or flaxseed muffins in one of the following 
orders: (1) Flaxseed once a day: three ground flaxseed muf-
fins with breakfast, one control muffin with lunch and din-
ner; (2) Flaxseed 3 times a day: one ground flaxseed muffin 
and two control muffins at breakfast and one flaxseed muffin 
at lunch and dinner; (3) Control muffins three times a day: 
three control muffins at breakfast and one control muffin at 
lunch and dinner.
On the follow-up sessions the participants attended the 
Oxford Brookes Centre for Nutrition and Health in the 
morning between 7.00 and 9.00 h after an overnight fast for 
the CGMS sensor removal. One final capillary finger-prick 
glucose reading was taken to calibrate the sensors before 
removing. There was a washout of at least 1 week between 
the test days. The wash out period was needed to minimise 
the carry over effect between the different treatments and 
was based on previous similar studies [19, 20].
Continuous glucose monitoring system sensor
Measurement of the 24-h glucose response was made using 
the Medtronic MiniMed  iPro®2 Professional Continuous 
Glucose Monitoring (Northridge, CA, USA) which recorded 
glucose levels every 5 min, giving a total of 288 readings 
over 24 h. The CGMS is a technology that has been previ-
ously used in other studies [21, 22]. This technology pro-
vides a full view of the glycaemic level every 5 min, to 
potentially show when and to what extent, an intervention 
affects the glycaemic response. It also allows the participants 
to continue their daily lives and activities uninterrupted [21, 
23, 24]. O’Riordan et al. [25] found that the CGMS perfor-
mance on two occasions over a 12-month period were reli-
able, reproducible and repeatable.
Using an applicator or self-insertion device, a thin plas-
tic sensor is inserted just under the skin of the abdomen 
by trained personnel. The receiver can store information 
for later use and long-term data can be downloaded to a 
computer programme CareLink iPro Software, which is a 
Web-based system, designed to generate reports and store 
data [26, 27].
Muffins
The muffins (flaxseed and control) were prepared following 
a standard recipe and the flaxseed muffins were prepared by 
replacing 48% of the flour in the control muffins with ground 
flaxseed each flaxseed muffins contain 10 g ground flax-
seed. A 150 g sample of each muffin type was analysed for 
nutritional content by Eurofins Scientific Food Testing Ltd. 
(Wolverhampton, UK) (Table 1). To prepare the muffins, 
first the dry ingredients (flour, sugar, baking soda, baking 
powder, nutmeg and cinnamon) were sifted and thoroughly 
mixed together with ground flaxseed if required. The banana 
was mashed and the liquid ingredients (semi-skimmed milk, 
butter, vanilla and eggs) were mixed in before adding to the 
dry ingredients. All muffin mixtures were placed into non-
stick petite muffin cups tray and baked at 190 °C (375 ºF) in 
a pre-heated oven for 20 min. After baking, the muffins were 
allowed to cool for 10 min before they were then removed 
from the tray. Then they removed from the tray for complete 
cooling on a wire rack for 30 min.
Dietary intervention
The participants were provided with pre-packaged meals for 
the evening meal before the test day and all meals for the test 
days. The meals were designed to meet the dietary reference 
values for energy and macronutrients for males and females 
based on the recommendations of the Scientific Advisory 
Committee on Nutrition [28]. The meals and snacks were 
made up from control or flaxseed muffins, orange juice, 
Greek style yoghurt, apple, hummus sandwich, green salad, 
vegetable lasagne, low fat berry medley yoghurt, nuts, 
orange, grapes and an oat and honey bar. Each food was 
labelled with the time that it should be consumed, as well 
as the meal type.
All meals were planned using Nutritics software ver 
5.022 (Nutritics LTD, Dublin, Ireland) based on for a healthy 
standard adult males and females; if the meal components 
were not on the Nutritics database, all the energy and macro-
nutrient information which was needed to plan the meals for 
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each test day was inserted manually according to the nutri-
tion facts label on that product.
Analysis of continuous glucose monitoring system 
data
All data from the sensors were downloaded to the Care-
Link iPro Software (MiniMed, Fridley, Minnesota) for each 
participant, which was coded with the participant’s number 
and the test number; all capillary results for blood glucose 
levels were inserted manually for each test treatment. All the 
times that the meals were consumed were inserted manu-
ally and all the data were then exported to Microsoft Excel 
(Windows version 2010) to complete the data analysis. One 
day (24-h data with 288 glucose readings) was determined 
to be from 06:00 on day 1 to 06:00 on day 2. For each test 
day, the following measurements were performed: Mean 
blood glucose concentration for 24 h, day (06.00–22.00 h), 
night (22.00–06.00 h) and pre–post each main meal was 
recorded. The blood glucose iAUC was also calculated geo-
metrically for each participant’s blood glucose response with 
the 06.00 h glucose result used as the baseline. Blood glu-
cose peak values for each main meal, as well as the time to 
peak were also recorded. The standard deviation calculated 
for all above measurements, except for mean blood glucose 
concentration over 24 h, day and night, where standard error 
was calculated.
Gastrointestinal symptoms
A gastrointestinal symptoms questionnaire was provided to 
be filled in after each meal for 24 h after each test day. The 
questionnaire was used to assess four different gastrointesti-
nal symptoms nausea, abdominal cramping, distension and 
flatulence. Participants rated the frequency and the severity 
of those symptoms. The scales were used to assess frequency 
(100 mm = ‘much more often than normal’ to 0 mm = ‘not 
more often than normal’) and severity (100 mm = ‘very 
severe’ to 0 mm = ‘none’) of the symptoms [26].
Statistical analysis
The required sample size for this study was estimated to be 
15 to be able to detect a 5% difference between 3 days in 
the overall blood glucose iAUC with the confidence level as 
95% and for a medium effect size, with α-0.05 (two-tailed) 
using G*power (Version 3.0.10). The power of study was 
Table 1  Muffin formulation for twelve muffins and nutrient profile per 100 g
Ingredients Muffin formulation
Unit Control Flaxseed
Melted butter g 75 75
Self-rising flour g 250 130
Flaxseed g – 120
Baking powder g 5 5
Bicarbonate of soda g 2.5 2.5
Ground cinnamon g 2.5 2.5
Nutmeg g 2.5 2.5
Caster sugar g 115 115
Vanilla extract ml 5 5
Large ripe bananas g 240 240
Medium eggs g 106 106
Semi skimmed milk ml 125 125
Ingredients Nutrient profile/100 g
Control Ground flaxseed
Crude protein (g) 5.5 7.2
Carbohydrate (avail) (g) 40.9 30.8
Total sugars (g) 18.7 18.2
Total fat (g) 8.5 14.9
Total fibre (AOAC) (g) 1.6 4.9
Energy (kcal) 265 296
Energy (kJ) 1120 1240
Saturated fatty acids (g) 4.8 6.9
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90% and the number of participants was based on the previ-
ous studies [29, 30].
Statistical analysis was performed using SPSS software, 
(Statistical Package for the Social Sciences) version 25, 
(Chicago, USA). Prior to statistical analysis, the normality 
of the data was assured using the Shapiro–Wilks statistical 
test to investigate the normality of the data; where data were 
not normally distributed, non-parametric tests were used.
All results were reported as the mean ± SD or SEM (not 
normally distributed data). Differences in mean blood glu-
cose concentration, time to peak, iAUC and gastrointestinal 
symptoms between the three test days were assessed using 
repeated measures ANOVA followed by Bonferroni correc-
tion for multiple comparisons if the data were parametric, 
or the Friedman test and Wilcoxon tests for non-parametric 
data. p < 0.05 was considered statistically significant.
The Pearson correlation coefficient and the method 
Bland–Altman technique [31] were used to assess the cor-




Fifteen healthy adults (ten female, five male) were recruited 
(Table 2).
Comparison of continuous glucose monitoring 
system and the capillary blood glucose readings
The results showed there was a strong correlation observed 
between the CGMS and the capillary blood finger-pricks 
carried out using Accu-Chek for the 405 paired glucose 
readings (r = 0.57, p < 0.001).
The Bland–Altman analysis indicated a good agreement 
between the CGMS and Accu-Chek for glucose level for 
405 paired readings (mean difference 0.1 mmol; 95% confi-
dence interval − 0.166 to − 0.034; limits of agreement − 1.4 
to 1.3 mmol). These results suggest that the data from the 
CGMS is reliable (Fig. 1).
Blood glucose profile
The blood glucose profile over 24 h for control muffins, 
once-a-day flaxseed muffins and three-times-a-day flax-
seed muffins is presented in (Fig. 2). All the investigations 
showed the same trend: splitting the portion of flaxseed to 
three times a day produced the lowest results, followed by 
flaxseed muffins once a day, while the control muffins had 
the highest glucose levels.
Blood glucose iAUC 
The blood glucose iAUC results (Table 3) show that adding 
flaxseed muffins to the diet whether in one portion or split 
Table 2  Baseline characteristics of fifteen participants (mean ± SD)
All (n = 15) Male (n = 5) Female (n = 10)
Age (y) 30.3 ± 9.1 25.0 ± 3.8 32.9 ± 10.0
Height (m) 1.7 ± 0.1 1.8 ± 0.1 1.6 ± 0.8
Weight (kg) 69.7 ± 13.3 81.4 ± 8.4 63.8 ± 11.8
BMI (kg/m2) 24.1 ± 2.9 24.6 ± 2.8 23.8 ± 3.1
Body fat% 25 ± 9.3 18.2 ± 5 29.4 ± 8.9
Fasting blood glu-
cose (mmol/l)
5.0 ± 0.3 5.0 ± 0.5 5.0 ± 0.3
Fig. 1  a Pearson regression of 405 paired glucose measurements 
between the Continuous Glucose Monitoring Systems (CGMS) and 
finger-prick blood glucose monitoring device (Accu-Chek) data. b 
Bland–Altman analysis of 405 paired glucose measurements between 
the CGMS and Accu-Chek data
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over three times a day, had the effect of lowering the blood 
glucose iAUC over 24 h, this was significant between the 
control muffins and flaxseed three times a day (p = 0.014). 
During the night there were significant differences between 
the control muffins and both flaxseed treatments (flaxseed 
once a day and flaxseed three times a day) (p = 0.005). 
There was no significant difference between the flaxseed 
treatments.
Absolute blood glucose level
The results for the absolute blood glucose level for each 
test day (control muffins, flaxseed muffin once per day 
and flaxseed muffins three times per day) over 24  h, 
over the daytime and over the night-time are shown in 
(Table 4). There were no significant differences in abso-
lute blood glucose between the test days for any exam-
ined time period, except for the night (22.00–6.00  h) 
where there was a significant reduction (p = 0.011) in 
blood glucose concentration after consuming flaxseed 
once (4.8 ± 0.3 mmol/l) compared to the control muffins 
(5.2 ± 0.1 mmol/l).
Fig. 2  Mean change in blood 
glucose (mmol/l) during 24 h, 
for each test day (n = 15)
Table 3  Blood glucose iAUC for all (24 h) and sections (daytime, morning, afternoon and evening, night-time) of each test day (mean ± SD)
a Significant difference (p < 0.05) compared to control muffins
Control muffins (mmol/l) Flaxseed muffins 
once/day (mmol/l)
Flaxseed muffins 3 
times/day (mmol/l)
P values
24 h iAUC (6.00–6.00 h) 1760.1 ± 1087.7 1214 ± 1065.4 893.8 ± 692.8a 0.014
Daytime iAUC (6.00–22.00 h) 1207.0 ± 728.2 931.7 ± 787.6 689.6 ± 448.4 0.127
Morning iAUC Day (6.00–12.00 h) 312.8 ± 183.9 287.4 ± 245.0 224.4 ± 139.8 0.627
Afternoon-evening iAUC Day (12.00–22.00 h) 768.8 ± 478.3 648.9 ± 564.2 470.3 ± 352.8 0.057
Night-time iAUC (22.00–6.00 h) 553.1 ± 382.3 282.3 ± 292.4a 204.2 ± 276.5a 0.005
Table 4  Average blood glucose 
concentration (mmol/l) for all 
(24 h) and sections (daytime, 
morning, afternoon and 
evening, night-time) of each test 
day (mean ± SEM)





Flaxseed muffins 3 
times/day (mmol/l)
P values
24 h (6.00–6.00 h) 5.2 ± 0.1 5.1 ± 0.1 5.2 ± 0.1 0.419
Day time (6.00–22.00 h) 5.2 ± 0.1 5.3 ± 0.1 5.4 ± 0.1 0.436
Morning (6.00–12.00 h) 4.9 ± 0.2 5.0 ± 0.2 5.3 ± 0.1 0.175
Afternoon-evening (12.00–22.00 h) 5.5 ± 0.1 5.4 ± 0.1 5.4 ± 0.1 0.745
Night-time (22.00–6.00 h) 5.2 ± 0.1 4.8 ± 0.3a 5.0 ± 0.1 0.011
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Blood glucose peak values and time to peak
The peak and time to peak of each of the three meals con-
sumed during the day (Table 5) were not significantly dif-
ferent between the test days.
Gastrointestinal symptoms
The effect of adding flaxseed to muffins on gastrointestinal 
symptoms 24 h post consumption was investigated and the 
results (Fig. 3) for the frequency and intensity for all the 
symptoms were similar for both flaxseed treatments. There 
was significant differences between both flaxseed treatments 
and the control muffins (p < 0.001) for the frequency and 
intensity of abdominal cramping and frequency of flatulence.
Discussion
The present study aimed to investigate the effect of adding 
flaxseed to muffins in one single portion, or split into three 
portions consumed throughout the day, on blood glucose 
Table 5  Blood glucose peak 
and time to peak for each 
main meal for each test day 
(mean ± SD)
Control muffins Flaxseed muffins 
once/day
Flaxseed muffins 3 
times/day
P values
Peak breakfast (mmol/l) 6.4 ± 0.8 6.0 ± 0.8 6.4 ± 1.0 0.207
Peak lunch (mmol/l) 6.4 ± 0.8 6.4 ± 1.0 6.4 ± 0.8 0.920
Peak dinner (mmol/l) 6.3 ± 0.4 6.4 ± 0.9 6.1 ± 0.7 0.307
Time to peak breakfast (min) 9.52 ± 1.5 9.50 ± 1.3 9.57 ± 1.6 0.970
Time to peak lunch (min) 15.00 ± 2.0 14.37 ± 1.7 14.45 ± 0.1 0.420
Time to peak dinner (min) 18.27 ± 6.6 19.50 ± 4.1 20.00 ± 4.7 0.169
Fig. 3  Mean frequency (a) and 
intensity (b) of some gastro-
intestinal symptoms 24 h post 
consumption for each test day 
(n = 15). *Significant difference 
(p<0.05) compared to control 
muffins
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profile using CGMS among healthy participants. The results 
of this study demonstrated that flaxseed muffins given 3 
times a day were effective at lowering and maintaining blood 
glucose levels over 24 h, compared to the control muffins 
and that both flaxseed treatments resulting in a lower blood 
glucose iAUC during the night. To the best of our knowledge 
there is currently no previous study that has investigated the 
effect of flaxseed on blood glucose response over an entire 
24-h period.
Reliable evidence has shown that the consumption of low 
GI food reduces large blood glucose fluctuations [2, 5]. It 
has been deduced from various studies that low GI foods 
ingested at breakfast reduce glycaemia after a subsequent 
standardised lunch; a phenomenon known as the “second-
meal effect”. In the short and medium terms, the consump-
tion of food which causes a second-meal effect may assist in 
sustaining low blood glucose concentrations, consequently 
reducing demands upon the insulin-mediated blood glucose 
regulatory systems [5]. This implies that first meal of the day 
(breakfast) may be the largest contributor to daily glycaemic 
control, which can result in improvements in glucose toler-
ance for subsequent meals such as lunch and dinner [32, 
33] if low GI foods are consumed. A possible mechanism is 
that breakfast may serve as primer to the insulin-sensitive 
tissues either by: (1) adjusting β-cell responses with changed 
incretin signalling or (2) an insulin sensitivity change fol-
lowing breakfast [34] as several studies have demonstrated 
greater insulin sensitivity in the morning than there is in the 
afternoon [35]. Although the results of the current study 
did not show differences after each of the individual meals, 
this effect is applicable to the current study as the results of 
iAUC over 24 h was significantly lower when flaxseed muf-
fins were consumed once a day, as well as when they were 
split across the day, compared to the control.
Many studies have looked at the effect of low GI foods 
on the blood glucose profile over 24 h among healthy par-
ticipants [2, 19, 21, 22]. The blood glucose profile over 
24-h for the above studies showed lower values following 
low GI food, especially during the night which is consistent 
with the results of the current study. The results for blood 
glucose iAUC during the night indicated that both flaxseed 
treatments produced lower readings than the control muffins. 
This is an important finding as much of the research to date 
on flaxseed has focused on the postprandial period; however, 
this demonstrates an improved hepatic insulin sensitivity, 
effectively decreasing hepatic glucose output throughout the 
night from just the consumption of either one single 30 g 
dose of flaxseed or three 10 g doses dispersed throughout 
the day.
Studies have shown that low GI diets in healthy adults 
can significantly lower fasting plasma glucose levels, which 
suggests that by switching to a low GI diet an improvement 
in hepatic insulin sensitivity that would effectively decrease 
the hepatic glucose output [19]. If these changes are applied 
over the long term they could potentially improve glucose 
control, which could result in a reduced chronic disease risk 
such T2D and CVD [21]. The impact of the reduction of 
blood glucose is a basic element of a low GI diet and the 
mechanisms underlying the metabolic impacts are multifac-
torial including glucose absorption, a reduced gastric empty-
ing rate, the food matrix, a slower small-intestinal transit as 
well as a decreased insulin response [36].
Flaxseeds contain many components known to impact 
blood glucose. It is well established that soluble dietary fibre 
can impact blood glucose control through delayed absorp-
tion within the gastrointestinal tract [37, 38]. The flaxseed 
muffins contained 4.9 g/100 g of fibre, which could be one 
of the main reasons for the changes in blood glucose seen 
in the current study. However, a recent study compared the 
intake of flaxseed or psyllium for 12 weeks and found flax-
seed to have superior impacts on glycaemic response [15] 
suggesting that other components may also contribute to 
the reduction in blood glucose. Flaxseed contains n-3 fatty 
acids alpha-linolenic acid has which has previously been 
shown to have a positive impact upon glycaemic control 
[37, 38]. A previous systematic review and meta-analysis 
[14] showed that there was a significant association between 
flaxseed supplementation and a reduction in blood glucose; 
however, when subgroup analysis was completed the signifi-
cant reduction in blood glucose were found only in studies 
using whole flaxseed but not flaxseed oil and lignan extract. 
However, the flaxseed oil was approaching significance 
(p = 0.08). Although the systematic review by Mohammadi-
Sartang et al. [14] highlighted that flaxseed lignan extract 
had no significant impact on blood glucose, plant lignan 
has been suggested to be able to lower the risk of cardio-
vascular diseases as well as inhibit the effect of develop-
ing type two diabetes by reducing inflammatory response 
and insulin resistance [39]. It has been shown that flaxseed 
lignan secoisolariciresinol diglucoside restricts expression 
of the phosphoenolpyruvate carboxykinase gene, which is 
considered the main enzyme in glucose synthesis in the 
liver [40, 41]. The richest source of plant lignans is flax-
seed which incorporates approximately 75–800 times more 
lignans in comparison to cereal grains, legumes, fruits and 
vegetables [9]. Finally, the protein in the flaxseed may also 
cause an increased insulin secretion resulting in decreased 
blood glucose [42]. It is likely that the reductions in blood 
glucose observed in the current study are due to the cumula-
tive effects of all of these components and their associated 
mechanism; however, further clinical trials are required to 
confirm this.
The amount of flaxseed added to the muffins in the cur-
rent study was based on a study by Wu et al. [43], who found 
that 30 g of milled flaxseed was effective in lowering blood 
glucose. Lipilina and Ganji [44] also demonstrated that 
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replacing 50% of the flour with ground flaxseed resulted 
in the most acceptable sensory evaluation compared to the 
control bread with wheat flour. In this study 30 g of flaxseed 
equalled a 48% replacement of flour. Ground flaxseed has 
also been shown to enhance the sensory attributes of muffins 
and could be added in high amounts (up to 50%) without any 
negative effects [45]. Due to a recent report from the Euro-
pean Food Safety Authority (EFSA), there have been some 
concerns about flaxseed due to the presences of cyanogenic 
glycosides, with many media outlets reporting that their 
intake should be limited especially in infants [46]. EFSA 
have now clarified this misconception. They highlight that 
14.7 g of flaxseed per day could reach the Acute Reference 
Dose. The Acute Reference Dose refers to an estimate of a 
daily oral exposure for an acute duration (24 h or less) to the 
human population that is likely to be without an appreci-
able risk of deleterious effects during a lifetime [47]. EFSA 
also highlight that there is overall uncertainty with the pre-
sent assessment, and it is more likely to overestimate than 
to underestimate the risk. However, future studies should 
examine smaller doses and the implications this can have on 
24-h glycaemic responses, particularly as flaxseeds are most 
often consumed with or as apart of breakfast. Furthermore, 
the extent of granularity of the flaxseed was not measured in 
the current study and little is known about how the degree 
of granularity effects glycaemic response and bioavailability 
of flaxseed nutrients.
The current study also investigated gastrointestinal symp-
toms compared with the control muffins and found that flax-
seed muffins of both treatment regimens caused some side 
effects on the gastrointestinal system. This is consistent with 
the results of Kristensen et al. [48], who found that 5 g flax-
seed dietary fibre supplementation for 12 weeks (with or 
without the addition of calcium) resulted in some gastro-
intestinal symptoms, especially abdominal pain, flatus and 
diarrhoea, which may be due to the amount of dietary fibre 
in the flaxseed. These results suggest flaxseed muffins can 
cause some gastrointestinal side effects, although they were 
not severe as the highest mean value was only 1.9 on a scale 
of 1–10.
Conclusions
The results of this study indicated that adding flaxseed to the 
diet can produce a lower glucose profile over 24 h in a free-
living context compared to the control muffins. Furthermore, 
flaxseeds were effective in improving the blood glucose pro-
file over the 24 h; however, to improve blood glucose both 
over 24 h and overnight flaxseeds are better consumed in 
smaller amounts dispersed throughout the day. This study 
provides important data about adding flaxseed to the diet for 
healthy individuals, which can improve glycaemic response 
throughout the day and overnight.
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